Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.
The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.
Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.
Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.
Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
The Depressive Disorders market in Estonia is experiencing steady growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors.Customer preferences in the Depressive Disorders market are shifting towards more personalized and holistic treatment options. Patients are increasingly seeking therapies that address not only the symptoms of depression but also the underlying causes. This has led to a rise in demand for psychotherapy, counseling, and alternative treatments such as mindfulness and meditation. Additionally, there is a growing preference for natural and organic products, leading to an increase in the consumption of herbal supplements and dietary changes.Trends in the market indicate a greater emphasis on mental health awareness and destigmatization of depressive disorders. This has resulted in increased public and private investments in mental health services, including the establishment of specialized clinics and the integration of mental health care into primary care settings. Furthermore, advancements in technology have facilitated the development of digital mental health solutions, such as telemedicine and mobile applications, which provide convenient access to therapy and support.Local special circumstances in Estonia contribute to the development of the Depressive Disorders market. The country has a high prevalence of depressive disorders, attributed to factors such as a high rate of alcohol consumption, long winters with limited sunlight, and a history of political and economic challenges. These unique circumstances have created a greater awareness and urgency to address mental health issues, leading to increased funding and resources dedicated to mental health care.Underlying macroeconomic factors also play a role in the growth of the Depressive Disorders market in Estonia. The country has experienced steady economic growth and rising disposable incomes, enabling individuals to seek and afford mental health services. Additionally, the government has implemented healthcare reforms aimed at improving access to mental health care, including the expansion of insurance coverage and the integration of mental health services into the public healthcare system.In conclusion, the Depressive Disorders market in Estonia is developing in response to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The shift towards personalized and holistic treatment options, increased mental health awareness, unique local circumstances, and favorable macroeconomic conditions are driving the growth of the market.
Most recent update: Jun 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.Additional Notes:
The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights